More

    Finance

    InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor Mesutoclax for Myelodysplastic Syndromes in China

    https://www.investing.com/news/press-releases/innocare-announces-approval-of-clinical-trial-of-bcl2-inhibitor-mesutoclax-for-myelodysplastic-syndromes-in-china-93CH-4069166 Investing.com

    NET POWER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power...

    https://www.investing.com/news/press-releases/net-power-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-net-power-inc--npwr-93CH-4069160 Investing.com

    Dollar surges after US court blocks Trump's tariffs

    https://www.investing.com/news/economy-news/dollar-rallies-after-us-court-blocks-trumps-tariffs-4069124 Reuters

    Arca Continental Opens Its Largest Distribution Center in Mexico with an Investment of Ps. 1.4 Billion

    https://www.investing.com/news/press-releases/arca-continental-opens-its-largest-distribution-center-in-mexico-with-an-investment-of-ps-14-billion-93CH-4069159 Investing.com

    Trump nominates his former defense attorney Emil Bove to serve as appellate judge

    https://www.investing.com/news/world-news/trump-nominates-emil-bove-to-serve-as-3rd-circuit-appeals-court-judge-4068628 Reuters

    Navitas semiconductor CEO Eugene Sheridan sells $9.68 million in stock

    https://www.investing.com/news/insider-trading-news/navitas-semiconductor-ceo-eugene-sheridan-sells-968-million-in-stock-93CH-4069156 Investing.com

    Latest articles

    spot_imgspot_img